Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 19

Results For "UK"

1148 News Found

71% of Indians targeted by health scams amid rise of AI-generated misinformation: McAfee study
Healthcare | June 23, 2026

71% of Indians targeted by health scams amid rise of AI-generated misinformation: McAfee study

Social media emerges as the primary channel for health-related scams, while influencer endorsements and AI-generated content amplify risks for consumers


AbbVie unveils 9-Yr CLL data showing lasting survival benefit for Venetoclax-based therapy
Biopharma | June 23, 2026

AbbVie unveils 9-Yr CLL data showing lasting survival benefit for Venetoclax-based therapy

Researchers emphasized that the benefit persisted well beyond the treatment period, reinforcing the clinical rationale for time-limited therapy in selected patients


Lubrizol and Polyhose launch advanced medical tubing plant in Chennai
Medical Device | June 21, 2026

Lubrizol and Polyhose launch advanced medical tubing plant in Chennai

The new facility will produce precision extruded medical tubing used in minimally invasive medical devices


Automated cell therapy manufacturing attracts US$1.1 Billion  across 34 funding rounds
Biopharma | June 20, 2026

Automated cell therapy manufacturing attracts US$1.1 Billion across 34 funding rounds

New Tracxn report highlights growing investor confidence in automated cell therapy production, with Cellares and Ori Biotech dominating funding and regulatory milestones


Govt pushes for identifying every missing TB case
Policy | June 20, 2026

Govt pushes for identifying every missing TB case

Over 28 crore people screened, TB incidence falls sharply as Centre urges states to intensify efforts ahead of July campaign deadline


ARScience Biotherapeutics appoints Gustavo Mahler as CEO
People | June 17, 2026

ARScience Biotherapeutics appoints Gustavo Mahler as CEO

Mahler brings more than 20 years of leadership experience spanning cell therapy, biopharmaceutical development, manufacturing, and global business management


We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene
interviews | June 16, 2026

We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene

Since 2022, we have grown threefold and our growth story is built on scale, scientific innovation and deep customer partnerships


Lilly’s Jaypirca cuts risk of disease progression or death by 45% in landmark trial
Clinical Trials | June 16, 2026

Lilly’s Jaypirca cuts risk of disease progression or death by 45% in landmark trial

The study enrolled 639 patients, nearly 80% of whom had previously received a covalent BTK inhibitor


T-CURX gets Swissmedic nod for first human trial of non-viral CAR-T therapy
Biopharma | June 15, 2026

T-CURX gets Swissmedic nod for first human trial of non-viral CAR-T therapy

Phase 1 study to evaluate Siglec-6-targeted CAR-T therapy in relapsed or refractory AML and CLL patients, marking a major milestone for T-CURX’s scalable non-viral CAR-T platform


Ryvu advances romaciclib program as FDA clears AML trial expansion
Clinical Trials | June 13, 2026

Ryvu advances romaciclib program as FDA clears AML trial expansion

The regulatory decision follows promising results from RIVER-81